#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15574	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2379	797.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1619	1619	C	978	C	978	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26208	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4080	801.6	0	.	n	.	0	T695C	SNP	695	695	T	1314	1314	C	961	C,T,A	959,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26208	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4080	801.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1956	1956	A	1069	A	1069	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26208	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4080	801.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2590	2590	C	876	C,A	874,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26208	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4080	801.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2664	2664	A	870	A	870	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26208	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4080	801.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3216	3216	C	920	C,G	919,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2096	folP	855	855	100.0	folP.l15.c4.ctg.1	2091	125.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1341	1343	AGC	210;211;209	A;G;C,T	210;211;208,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5036	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3868	162.5	1	SNP	p	S91F	1	.	.	271	273	TTC	826	828	TTC	173;177;176	T,C;T;C,T	172,1;177;175,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5036	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3868	162.5	1	SNP	p	D95G	1	.	.	283	285	GGC	838	840	GGC	177;180;178	G;G;C	177;180;178	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5036	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3868	162.5	1	SNP	p	G95N	0	.	.	283	285	GGC	838	840	GGC	177;180;178	G;G;C	177;180;178	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1918	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1980	121.0	1	SNP	p	G45D	0	.	.	133	135	GGC	808	810	GGC	205;205;207	G,T;G,A,T;C	204,1;203,1,1;207	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1088	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1611	84.3	0	.	n	.	0	A197.	DEL	197	197	A	842	842	A	208	A	208	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5096	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3503	181.6	1	SNP	p	D86N	0	.	.	256	258	GAC	824	826	GAC	202;200;203	G,C;A,C;C	201,1;199,1;203	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5096	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3503	181.6	1	SNP	p	R87I	0	.	.	259	261	CGT	827	829	CGT	203;203;203	C;G,C;T,C,G	203;202,1;201,1,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5096	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3503	181.6	1	SNP	p	R87W	0	.	.	259	261	CGT	827	829	CGT	203;203;203	C;G,C;T,C,G	203;202,1;201,1,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5096	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3503	181.6	1	SNP	p	S87R	1	.	.	259	261	CGT	827	829	CGT	203;203;203	C;G,C;T,C,G	203;202,1;201,1,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5096	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3503	181.6	1	SNP	p	S88P	0	.	.	262	264	TCC	830	832	TCC	203;201;203	T;C,A;C	203;200,1;203	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4040	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3211	157.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1784	1786	GGC	233;231;228	G;G,C;C	233;230,1;228	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4242	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2976	177.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1510	1512	GCA	239;241;239	G,T;C;A	238,1;241;239	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4242	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2976	177.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1513	1515	ATC	239;242;243	A;T,G;C	239;240,2;243	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4242	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2976	177.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1525	1527	GTG	241;239;240	G,T;T,A;G	240,1;238,1;240	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4242	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2976	177.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1525	1527	GTG	241;239;240	G,T;T,A;G	240,1;238,1;240	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4242	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2976	177.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2029	2031	ACC	253;254;256	A;C;C,A	253;254;255,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4242	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2976	177.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2083	2085	GCG	225;225;228	G,T;C,T,G;G	224,1;223,1,1;228	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4242	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2976	177.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2083	2085	GCG	225;225;228	G,T;C,T,G;G	224,1;223,1,1;228	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4242	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2976	177.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2206	2208	AGC	240;238;238	A,G,C;G;C,T	238,1,1;238;237,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4242	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2976	177.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2215	2217	GGC	229;230;232	G;G,A;C	229;229,1;232	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4242	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2976	177.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2233	2235	CCG	236;236;235	C,T,G;C;G,A,T,C	233,1,1;235;231,1,1,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5534	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3643	189.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1861	1863	CCG	220;221;219	C;C,G,A;G,A,T	220;219,1,1;217,1,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2256	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2361	119.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	812	812	C	169	C	169	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3542	porB1b	1035	1035	97.52	porB1b.l15.c30.ctg.1	1570	269.4	0	.	p	.	0	E38G	NONSYN	112	114	GAA	488	490	GGA	279;275;276	G;G;A	279;275;276	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3542	porB1b	1035	1035	97.52	porB1b.l15.c30.ctg.1	1570	269.4	0	.	p	.	0	G46S	NONSYN	136	138	GGC	512	514	AGC	264;264;264	A;G;C	264;264;264	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3542	porB1b	1035	1035	97.52	porB1b.l15.c30.ctg.1	1570	269.4	0	.	p	.	0	V98I	NONSYN	292	294	GTC	668	670	ATC	278;277;273	A;T,C;C	278;276,1;273	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3542	porB1b	1035	1035	97.52	porB1b.l15.c30.ctg.1	1570	269.4	0	.	p	.	0	A121V	NONSYN	361	363	GCC	737	739	GTC	265;269;269	G;T,C;C,G	265;268,1;268,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3542	porB1b	1035	1035	97.52	porB1b.l15.c30.ctg.1	1570	269.4	0	.	p	.	0	R143E	NONSYN	427	429	AGA	803	805	GAA	283;284;287	G;A;A	283;284;287	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3542	porB1b	1035	1035	97.52	porB1b.l15.c30.ctg.1	1570	269.4	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1007	1007	T	314	T	314	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11410	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5334	267.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1802	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1493	150.3	1	SNP	p	V57M	1	.	.	169	171	ATG	790	792	ATG	328;326;325	A;T;G	328;326;325	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
